Exact Sciences Corporation
EXAS
$45.66
-$1.81-3.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.56% | 11.57% | 10.37% | 11.91% | 13.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.56% | 11.57% | 10.37% | 11.91% | 13.54% |
| Cost of Revenue | 13.22% | 16.26% | 19.63% | 35.56% | 35.62% |
| Gross Profit | 12.25% | 9.52% | 6.49% | 3.52% | 5.59% |
| SG&A Expenses | 7.22% | 3.54% | 1.99% | 2.14% | 2.51% |
| Depreciation & Amortization | -1.67% | -103.34% | -- | -148.40% | -149.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.38% | 5.13% | 4.90% | 5.93% | 7.11% |
| Operating Income | 50.76% | 45.32% | 38.74% | 35.14% | 29.71% |
| Income Before Tax | -489.45% | -332.83% | -413.60% | 25.14% | 60.37% |
| Income Tax Expenses | -417.09% | -448.20% | -403.95% | 317.21% | 214.76% |
| Earnings from Continuing Operations | -474.39% | -324.54% | -403.97% | 24.13% | 59.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -474.39% | -324.54% | -403.97% | 24.13% | 59.46% |
| EBIT | 50.76% | 45.32% | 38.74% | 35.14% | 29.71% |
| EBITDA | 213.62% | 133.80% | 121.67% | 92.36% | 66.11% |
| EPS Basic | -464.23% | -315.26% | -390.03% | 25.81% | 60.38% |
| Normalized Basic EPS | 49.65% | 45.23% | 40.07% | 44.91% | 37.00% |
| EPS Diluted | -465.32% | -316.06% | -390.95% | 25.62% | 60.37% |
| Normalized Diluted EPS | 49.37% | 44.97% | 39.78% | 44.69% | 37.34% |
| Average Basic Shares Outstanding | 2.39% | 2.34% | 2.25% | 2.17% | 2.11% |
| Average Diluted Shares Outstanding | 1.91% | 1.85% | 1.77% | 1.68% | 2.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |